127. 前頭側頭葉変性症 Frontotemporal lobar degeneration Clinical trials / Disease details


臨床試験数 : 90 薬物数 : 87 - (DrugBank : 30) / 標的遺伝子数 : 39 - 標的パスウェイ数 : 88

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04680130
(ClinicalTrials.gov)
November 1, 20203/11/2020Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related DisordersClinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related DisordersPSP;CBD;PCA;LPA;Semantic Dementia;Semantic Aphasia;Behavioral Variant of Frontotemporal Dementia;FTD;PPA;Apraxia of SpeechDrug: C-11 PiB;Drug: AV1451 TauMayo ClinicNULLEnrolling by invitation21 YearsN/AAll500United States
2NCT01623284
(ClinicalTrials.gov)
March 20107/6/2012PiB PET Scanning in Speech and Language Based DementiasPiB PET Scanning in Speech and Language Based DementiasPPA;Primary Progressive Aphasia;Aphasia;Non-fluent Aphasia;Semantic Dementia;Apraxia of Speech;Primary Progressive Nonfluent Aphasia;Progressive AphasiaDrug: C-11 PiB;Drug: F-18 FDGMayo ClinicNULLCompleted18 YearsN/ABoth168Phase 1United States
3NCT00950430
(ClinicalTrials.gov)
April 200829/7/2009Imaging of Brain Amyloid Plaques in the Aging PopulationBrain Amyloid Imaging With Pittsburgh Compound B in Normal Aging, Mild Cognitive Impairment, and DementiaAlzheimer's Disease;Dementia With Lewy Bodies;Frontotemporal Dementia;Vascular DementiaDrug: Pittsburgh Compound B (C-11 PiB);Drug: F-18 FDG;Drug: Tau (18-F-AV-1451)Mayo ClinicNational Institute on Aging (NIA)Enrolling by invitation30 Years100 YearsAll8000Phase 4United States